IL1B and infection: Protein and mRNA levels of IL-6 (Fig. 3I) and IL-1β (Fig. 3J) were significantly reduced in ASO MIR99AHG treated BMDMs compared to controls following IL-4/IL-13 stimulation and Mtb HN878 infection.